PMVP (PMV Pharmaceuticals) EBITDA Margin %: 0.00% (As of Mar. 2026)

What is PMV Pharmaceuticals EBITDA Margin %?

PMV Pharmaceuticals PMVP +3.48% 34 EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus rates PMVP with a GF Score™ of 34/100. The stock has 2 warning signs investors should review. Among 943 Biotechnology companies, PMV Pharmaceuticals ranks worse than 106044.43% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. PMV Pharmaceuticals's EBITDA for the three months ended in Mar. 2026 was $-18.99 Mil. PMV Pharmaceuticals's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, PMV Pharmaceuticals's EBITDA margin for the quarter that ended in Mar. 2026 was 0.00%.

PMV Pharmaceuticals (NAS:PMVP) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

PMV Pharmaceuticals EBITDA Margin % Related Terms

PMV Pharmaceuticals EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for PMV Pharmaceuticals's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PMV Pharmaceuticals EBITDA Margin % Chart

PMV Pharmaceuticals Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

EBITDA Margin %

Get a 7-Day Free Trial

0.00

PMV Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
EBITDA Margin %	Get a 7-Day Free Trial															0.00	0.00	0.00	0.00	0.00

PMVP vs MNOV, TCRX, BSEM: EBITDA Margin % Comparison

For the Biotechnology subindustry, PMV Pharmaceuticals's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

PMV Pharmaceuticals EBITDA Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PMV Pharmaceuticals's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where PMV Pharmaceuticals's EBITDA Margin % falls into.

Save Embed

34GF Score

PMV Pharmaceuticals Inc PMVP

EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

PMV Pharmaceuticals EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

PMV Pharmaceuticals's EBITDA Margin % for the fiscal year that ended in Dec. 2025 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2025 )	/	Revenue (A: Dec. 2025 )
	=	-86.073	/	0
	=	%

PMV Pharmaceuticals's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %	=	EBITDA (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-18.985	/	0
	=	%

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 0.00% mean?

PMV Pharmaceuticals (PMVP) has a EBITDA Margin % of 0.00% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMV Pharmaceuticals and its competitors. According to the industry distribution chart, PMV Pharmaceuticals ranks #999999 out of 943 companies in the Biotechnology industry.

Is PMV Pharmaceuticals' EBITDA Margin % too high?

PMV Pharmaceuticals' current EBITDA Margin % is 0.00%. Based on the distribution chart, PMV Pharmaceuticals ranks #999999 out of 943 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PMV Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.

How does PMV Pharmaceuticals' EBITDA Margin % compare to MNOV and TCRX?

According to the Biotechnology industry distribution chart, PMV Pharmaceuticals ranks #999999 out of 943 companies for EBITDA Margin %. This places PMV Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Biotechnology company?

A good EBITDA Margin % depends on the Biotechnology industry context. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on PMV Pharmaceuticals and its competitors. PMV Pharmaceuticals's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is PMV Pharmaceuticals stock overvalued right now?

PMV Pharmaceuticals (PMVP) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. PMV Pharmaceuticals' overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For PMV Pharmaceuticals (PMVP), the current EBITDA Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PMV Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies MNOV TCRX BSEM CING IMA XLO MCRB FLNA PLRX BYSI VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Address 400 Alexander Park Drive, Suite 301, Princeton, NJ, USA, 08540

Website https://www.pmvpharma.com

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which can eliminate cancer cells. The key product candidate, rezatapopt, is designed to be an orally available small molecule that structurally corrects the mutant p53 protein with the Y220C mutation. Currently, the product candidates are undergoing preclinical and clinical testing, and company relies on third parties for the manufacture after marketing approvals.

34GF Score

Get the complete analysis for PMVP

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19

Price

View PMVP Analysis

See EBITDA Margin % data for all stocks →